tiprankstipranks
Trending News
More News >
Fate Therapeutics (DE:F6T)
FRANKFURT:F6T
Germany Market
Advertisement

Fate Therapeutics (F6T) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Fate Therapeutics’s (F6T) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting Fate Therapeutics is a Sell.
Fate Therapeutics’s (F6T) 20-Day exponential moving average is 1.09, while Fate Therapeutics’s (F6T) share price is €1.35, making it a Buy.
Fate Therapeutics’s (F6T) 50-Day exponential moving average is 0.99, while Fate Therapeutics’s (F6T) share price is €1.35, making it a Buy.

Fate Therapeutics (F6T) Pivot Points

Oct 18, 2025, 03:52 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.25
1.25
1.25
1.25
1.25
1.25
1.25
Fibonacci
1.25
1.25
1.25
1.25
1.25
1.25
1.25
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (F6T) Moving Averages

Oct 18, 2025, 03:52 PM
Period
Simple
Exponential
MA5
1.29Buy
1.27Buy
MA10
1.20Buy
1.20Buy
MA20
1.03Buy
1.09Buy
MA50
0.93Buy
0.99Buy
MA100
0.97Buy
1.00Buy
MA200
1.02Buy
1.19Buy
Fate Therapeutics’s (F6T) 10-Day exponential moving average is 1.20, while Fate Therapeutics’s (F6T) share price is €1.35, making it a Buy.
Fate Therapeutics’s (F6T) 100-Day exponential moving average is 1.00, while Fate Therapeutics’s (F6T) share price is €1.35, making it a Buy.
Fate Therapeutics’s (F6T) stock price is €1.35 and Fate Therapeutics’s (F6T) 50-day simple moving average is 0.93, creating a Buy signal.
Fate Therapeutics’s (F6T) stock price is €1.35 and Fate Therapeutics’s (F6T) 100-day simple moving average is 0.97, creating a Buy signal.
Fate Therapeutics’s (F6T) stock price is €1.35 and Fate Therapeutics’s (F6T) 200-day simple moving average is 1.02, creating a Buy signal.

Fate Therapeutics (F6T) Technical Indicators

Oct 18, 2025, 03:52 PM
Name
Value
Implied Action
RSI (14)
68.55
Neutral
STOCH (9,6)
68.20
Neutral
STOCHRSI (14)
78.81
Neutral
MACD (12,26)
0.12
Sell
ADX (14)
29.12
Neutral
Williams %R
-3.46
Sell
CCI (14)
111.22
Sell
ATR (14)
0.06
-
Ultimate Oscillator
68.75
Neutral
ROC
68.49
Buy
Fate Therapeutics’s (F6T) Relative Strength Index (RSI) is 68.55, creating a Neutral signal.
Fate Therapeutics’s (F6T) Trend Strength Indicator (ADX) is 29.12, creating a Neutral signal.
Fate Therapeutics’s (F6T) Commodity Channel Index (CCI) is 111.22, creating a Sell signal.
Fate Therapeutics’s (F6T) Price Rate of Change (ROC) is 68.49, creating a Buy signal.

FAQ

Is F6T a Buy, Hold, or Sell?
Based on F6T’s technical indicators, F6T is a Buy.
    What is F6T’s RSI (14)?
    F6T’s RSI (14) is 68.55, which suggests F6T is a Neutral.
      What is F6T’s MACD?
      F6T’s MACD is 0.12, which suggests F6T is a Sell.
        What is F6T’s 5-day moving average?
        F6T’s 5-day moving average is 1.29, which suggests F6T is a Buy.
          What is F6T’s 20-day moving average?
          F6T 20-day moving average is 1.03, which suggests F6T is a Buy.
            What is F6T’s 50-day moving average?
            F6T’s 50-day moving average is 0.93, which suggests F6T is a Buy.
              What is F6T’s 200-day moving average?
              F6T’s 200-day moving average is 1.02, which suggests F6T is a Buy.
                What is F6T’s Williams % R (14)?
                F6T’s Williams % R (14) is -3.46, which suggests F6T is a Sell.
                  What is F6T’s CCI (14)?
                  F6T’s CCI (14) is 111.22, which suggests F6T is a Sell.
                    What is the share price of Fate Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis